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Bacillus thuringiensis Cry1A toxins are versatile proteins with multiple
modes of action: two distinct pre-pores are involved in toxicity
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Alejandra BRAVO*1
*Instituto de Biotecnolog´ıa, Universidad Nacional Auto´noma de Me´xico, Apdo. Postal 510-3, Cuernavaca 62250, Morelos, Mexico
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Cry proteins from Bacillus thuringiensis are insecticidal PFTs
(pore-forming toxins). In the present study, we show that two
distinct functional pre-pores of Cry1Ab are formed after binding
of the protoxin or the protease-activated toxin to the cadherin
receptor, but before membrane insertion. Both pre-pores actively
induce pore formation, although with different characteristics,
and contribute to the insecticidal activity. We also analysed the
oligomerization of the mutant Cry1AbMod protein. This mutant
kills different insect populations that are resistant to Cry toxins,
but lost potency against susceptible insects. We found that the
Cry1AbMod-protoxin efficiently induces oligomerization, but not
the activated Cry1AbMod-toxin, explaining the loss of potency of
Cry1AbMod against susceptible insects. These data are relevant
for the future control of insects resistant to Cry proteins. Our data
support the pore-formation model involving sequential interaction
with different midgut proteins, leading to pore formation in the
target membrane. We propose that not only different insect targets
could have different receptors, but also different midgut proteases
that would influence the rate of protoxin/toxin activation. It is
possible that the two pre-pore structures could have been selected
for in evolution, since they have differential roles in toxicity
against selected targets, increasing their range of action. These
data assign a functional role for the protoxin fragment of Cry
PFTs that was not understood previously. Most PFTs produced
by other bacteria are secreted as protoxins that require activation
before oligomerization, to finally form a pore. Thus different pre-
pores could be also part of the general mechanism of action of
other PFTs.
Key words: Bacillus thuringiensis, Cry toxin, mechanism of
action, oligomerization, pore-forming toxin, pre-pore.
INTRODUCTION
PFTs (pore-forming toxins) are one of the most important groups
of virulent factors that are critical for the effective pathogen
attack of their targets [1,2]. Different pathogenic bacteria and
mushrooms produce them. In addition, the mammalian perforin,
or C9 from the complement system, generates pores in target
pathogens [3]. PFTs are also produced by Bacillus thuringiensis,
during the sporulation phase of growth. These bacteria produce
Cry and Cyt PFTs that are active against different insect
pests in agriculture or are vectors of human diseases [4].
Of the many groups of Cry toxins presently described (see
http://www.btnomenclature.info/), the 3d-Cry (three-domain Cry)
toxins represent the largest family. Several members of these 3d-
Cry toxins have been expressed in transgenic plants, resulting not
only in efficient control of insect pests, but also in significant
reduction in the use of chemical insecticides in the field [6,7].
The loss of PFT activity results in significant reduction of
virulence in diverse pathogens [1,2]. Thus understanding the
mechanism of membrane insertion of these proteins would
address a fundamental question in biology. Different models have
been proposed to describe how the pores are formed in the target
membranes before causing osmotic lysis and cell death [1–4].
The main unsolved questions are focused on how PFTs affect the
target membranes, in particular whether sequential interactions
with different receptors are required in vivo, and whether the pore-
forming oligomer is assembled before or after the monomeric
toxin is inserted into the membrane.
In the case of Cry1A PFT, one model proposes a sequential
binding interaction of the toxin with different midgut proteins
(receptors), leading to the assembly of a pre-pore oligomeric
structure before it inserts into the membrane and forms a pore.
The first step in this model is a low-affinity interaction of
monomeric activated toxin with APN (aminopeptidase N) or
ALP (alkaline phosphatase) receptors (Kd 100–200 nM), which
are highly abundant in the membrane [8,9]. This important step
locates the toxin in close proximity to the microvilli membrane.
The second step is a high-affinity interaction with a cadherin
receptor (Kd 1 nM) that involves interaction of three different
epitopes, both in the toxin and in the cadherin molecule [10,11].
This complex interaction facilitates an additional cleavage at
the N-terminal end of the toxin, triggering oligomerization of the
protein [12,13]. The oligomeric structure gains a 100–200-fold
higher binding affinity to APN and ALP receptors (Kd 0.5 nM)
[8,9], facilitating the insertion of the pre-pore into membrane lipid
rafts [12,13] forming the lytic pore in the midgut cells [8,12].
The requirement for cleavage of the N-terminal region to form
oligomeric structures responsible for pore-formation activity was
questioned [14] because Cry1A, Cry1C and Cry4Ba monomers
are able to form pores in vitro, in PLBs (planar lipid bilayers),
in the absence of receptors or proteases [15–24]. Hence an
alternative model has been proposed where the pore is formed
after insertion of activated monomeric toxin into the membrane
[14]. In this model, interaction with any one of the toxin receptors
that are present in insect midgut cells, such as cadherin, APN or
ALP, would facilitate toxin insertion into the membrane. After
Abbreviations: ABCC2, ATP-binding cassette C2; ALP, alkaline phosphatase; APN, aminopeptidase N; BBMV, brush border membrane vesicle; 3d-Cry,
three-domain Cry; PC, phosphatidylcholine; PE, phosphatidylethanolamine; PFT, pore-forming toxin; PLB, planar lipid bilayer; SUV, small unilamellar
vesicle.
1 Correspondence may be addressed to either of these authors (email mario@ibt.unam.mx or bravo@ibt.unam.mx).
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
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monomeric toxin inserts into the membrane, oligomerization
follows in the membrane plane, forming pores that kill cells [14].
However, there are significant problems with the latter model.
For example, insertion of trypsin-activated toxin into the bilayer
was not efficient, since, in some cases, pores failed to appear
at all and/or required special activation processes as well as
special procedures to incorporate the toxin into the bilayer such
as disruption and repainting the bilayer or microinjection of the
toxin directly into the hole of the bilayer chamber followed by
chloroform evaporation [15,19,21,23,24]. In addition, the pores
that were formed displayed several subconducting states [16–
21,24] and a variety of kinetic behaviours, such as complex
activity patterns, rapid flickering or slow gating and long-lasting
subconducting states, were observed [19–21]. Furthermore, most
of the reported records of the pores induced by these toxins last
only for 1–4 s [14,15,17–24], showing bursts of up to ten different
levels [18,20] as well as toxin washout of the membrane [16].
In contrast, in the sequential bind model, it is proposed that
a pre-pore is formed after activation of Cry1Ab protoxin in
the presence of cadherin receptor forming a 250 kDa structure.
The size-exclusion-purified Cry1Ab 250 kDa oligomers readily
incorporate into the bilayer, inducing ion pores with a stable
conductance state and high open probability [16,25–27] for
several minutes [16]. This pore activity could be observed at
20-fold lower toxin concentrations (6 nM) than that observed
with monomeric trypsin-activated toxin under the same conditions
(150 nM), indicating that insertion of pure oligomeric structures is
more efficient than that of the monomeric toxin [16]. Nevertheless,
direct comparison of pore formation between trypsin-activated
toxin and oligomeric structures of Cry toxin has only been
presented in one previous report [16] and more studies are needed.
In the present study, we provide further evidence in support
of the sequential binding model. We show that Cry1Ab protoxin
or activated toxin bind cadherin with similar affinities and two
different pre-pores are produced depending on which of these
molecules interacts with cadherin in the presence of insect midgut
proteases. These pre-pores differ in their apparent size, sensitivity
to temperature, ability to insert into synthetic membranes and pore
characteristics. Our data suggest that the mechanism of action of
Cry PFTs is complex, showing multiple mechanisms of action.
EXPERIMENTAL
Cry1Ab toxin purification
B. thuringiensis strains expressing Cry1Ab, Cry1Ab F371A
[8,28] or Cry1AbMod [29] were grown for 3 days at 30 ◦C
in nutrient broth sporulation medium, supplemented with
erythromycin at 10 μg·ml− 1. After complete sporulation, the
harvested products were washed twice in 300 mM NaCl
and 10 mM EDTA, and crystal inclusions were purified
using discontinuous sucrose gradients [30]. Protoxins were
produced by solubilizing crystal inclusions in an alkaline
buffer (50 mM Na2CO3 and 0.2% 2-mercaptoethanol, pH 10.5)
for 2 h at 37 ◦C. The soluble protoxins were recovered after
centrifugation at ∼18400 g for 20 min). Trypsin-activated toxins
were obtained by treatment of soluble protoxin with trypsin
[TPCK (tosylphenylalanylchloromethane)-treated trypsin from
bovine pancreas (Sigma–Aldrich)] at a mass ratio of 1:50
(trypsin/toxin) for 2 h at 37 ◦C after lowering the pH to 8.5 by
adding 1 M Tris buffer (pH 8.5) at a 1:4 (v/v) ratio. PMSF (1 mM
final concentration) was added to stop proteolysis. Activated
proteins were purified by anion-exchange chromatography Mono
Q–Sepharose fast flow (GE Healthcare) in an ¨AKTA FPLC
System (GE Healthcare), using a 50 mM Tris/HCl and 50 mM
NaCl (pH 8.5) buffer, and a linear NaCl concentration gradient
from 50 to 300 mM. Protein concentrations were determined by
the method of Bradford, using BSA as a standard.
Expression and purification of a cadherin fragment, ALP and APN
The Manduca sexta cadherin protein fragment (CR7–CR12)
containing residues 810–1480 was expressed in Escherichia coli
ER2566 cells as reported previously [26]. The cadherin fragment
was purified using nickel affinity according to the manufacturer’s
instructions (Qiagen). APN and ALP proteins were produced in
E. coli and purified as reported previously [31].
ELISA binding assays
A 1 μg amount of the cadherin fragment suspended in 100 μl
of PBS was used to coat each well of a 96-well ELISA plate,
overnight at 4 ◦C. Unbound cadherin fragments were removed
and the ELISA plate was washed three times with 200 μl of PBS.
Then, 200 μl of PBS, containing 2% (w/v) non-fat dried skimmed
milk powder, was added and incubated at 37 ◦C for 2 h. Each
well was washed three times with PBS, followed by incubation
with different toxin or protoxin dilutions in PBS for 1 h at 37 ◦C.
Excess unbound toxin was removed by two washing steps and
each well was incubated with anti-Cry1Ab antibody (1/20000
dilution) for 1 h at 37 ◦C. After washing, horseradish-peroxidase-
conjugated rabbit antibody (1/10000 dilution) was added (37 ◦C
for 1 h). After additional washing, 100 μl of freshly prepared
substrate solution composed of 5 mg of o-phenylenediamine
(Sigma–Aldrich) in substrate buffer (0.1 M sodium phosphate,
pH 5) plus 12 μl of 30% H2O2 (Sigma–Aldrich) was added and
absorbance at 490 nm was measured. Data were analysed using
Scatchard analysis with SigmaPlot (Systat Software).
Analysis of oligomerization in solution
Oligomeric Cry1Ab structures were obtained by incubating
0.5 μg of the pure trypsin-activated toxin or 1.5 μg of protoxin
with the cadherin fragment CR7–CR12 at a mass ratio of 1:4
(Cry1Ab/ cadherin fragment) for 30 min at 37 ◦C in a total volume
of 100 μl of alkaline buffer. We used a higher amount of protoxin
since half of it is degraded during activation with proteases.
Subsequently the same mixture was incubated for 30 min in the
presence of 0.5 μg of trypsin or 0.5 μl of midgut juice isolated
from M. sexta as described in [32]. The reaction was stopped
by adding 1 mM PMSF. Control samples that contained only the
activated toxin or the protoxin, without cadherin or proteases,
were included. Then, 4× Laemmli sample buffer (0.125 M
Tris/HCl, 4% SDS, 20% glycerol, 10% 2-mercaptoethanol and
0.01% Bromophenol Blue) was added to the samples and they
were divided into three tubes, each incubated for 5 min at a
different temperature (25, 50 or 100 ◦C). These samples were
then separated by SDS/PAGE (8% gels) and electrotransferred
on to PVDF membranes (Millipore), which were used for Western
blot assays as described below.
Incorporation of oligomers into SUVs (small unilamellar vesicles)
SUV liposomes were prepared as described previously
[33] using PE (phosphatidylethanolamine), egg-yolk PC
(phosphatidylcholine) and cholesterol (Avanti Polar Lipids) in a
7:3:2 molar proportion as described previously [14]. We selected
this lipid composition since it was used previously to analyse
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
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pore-formation activity of different Cry toxins [17–19,20–24].
Lipids were hydrated in 10 mM Ches and 150 mM KCl (pH 9)
at 2.6 μmol in 2.6 ml (1 mM final concentration) (1.52 μmol of
PE; 0.65 μmol of PC and 0.43 μmol of cholesterol). SUVs were
prepared by sonication in a Branson-1200 bath sonicator (Branson
Ultrasonic) and used within 2 days of their preparation. Protoxin
or activated toxin were incubated with cadherin fragment in the
absence or presence of trypsin in solution as described above
and these samples were incubated for 1 h at room temperature
(25 ◦C) with 50 μl of SUVs before analysing their pore formation.
Samples were centrifuged at 157000 g for 30 min at 4 ◦C, the
supernatants were removed, and the pellets were washed with
100 μl of 10 mM Ches and 150 mM KCl (pH 9) and then
centrifuged again. The final pellets were suspended in 60 μl of
the same buffer and analysed by Western blotting as described
below or suspended in 100 μl for pore-formation assays in black
lipid bilayers as described below.
M. sexta midgut BBMV (brush border membrane vesicle)
purification
M. sexta midgut tissues from third instar larvae were dissected
and stored immediately at − 70 ◦C. BBMVs were prepared by
the magnesium precipitation method without protease inhibitors
[34] and stored at − 70 ◦C until used. The BBMV protein
concentrations were determined with the Lowry DC protein assay
(Bio-Rad Laboratories) using BSA as a standard.
Analysis of oligomerization in BBMVs
Cry1Ab oligomerization in BBMVs was analysed after incubation
of 0.5 μg of Cry1Ab toxin or protoxin with 10 μg of BBMV
protein for 1 h at 37 ◦C in a total volume of 50 μl of alkaline buffer
(pH 10.5). A control sample contained only BBMVs. The reaction
was stopped with 1 mM PMSF and the BBMVs were recovered
by centrifugation at 157000 g for 30 min at 4 ◦C. The pellet was
washed once with 100 μl of alkaline buffer, and finally suspended
in 60 μl of the same buffer. Then, 4× Laemmli sample buffer was
added and the sample was divided into three tubes, which were
incubated for 3 min at different temperatures as described above.
After heating, these samples were separated by SDS/PAGE (8%
gels), electrotransferred on to PVDF membranes and revealed by
Western blot assays as described below.
Western blot assays
PVDF membranes were blocked with 5% (w/v) non-fat dried
skimmed milk powder in washing buffer (PBS, pH 7.4, plus
0.1% Tween 20), for 1 h at room temperature. The membranes
were rinsed once with the same buffer. Cry1Ab was detected
with polyclonal anti-Cry1Ab antibodies and the cadherin receptor
protein was detected with polyclonal anti-cadherin antibodies
(1/30000 dilution; 1 h). Visualization was performed with goat
anti-rabbit secondary antibody coupled to horseradish peroxidase
(Santa Cruz Biotechnology) (1/25000 dilution; 1 h), followed by
SuperSignalTM chemiluminescence substrate (Pierce), according
to the manufacturer’s instructions.
Both the anti-Cry1Ab and anti-cadherin antibodies were
produced in New Zealand white rabbits that were immunized
subcutaneously. For the anti-Cry1Ab antibodies, a mixture of
oligomeric and monomeric Cry1Ab structures were used for
immunization. These structures were obtained after proteolytic
activation of Cry1Ab protoxin in the presence of scFv73
antibody, which mimics one of the binding sites of the
cadherin receptor [35]. For anti-cadherin antibodies, the cadherin
fragment produced in E. coli was used for immunization
[26]. The rabbits were boosted three times with 1 mg of the
Cry1Ab monomeric/oligomeric mixture or with the cadherin
fragment, each mixed with incomplete Freund’s adjuvant,
at 15-day intervals. All procedures involving animals were
conducted according to the ethical guidelines of the Instituto de
Biotecnologı´a, Universidad Nacional Auto´noma de Me´xico.
Planar lipid bilayer experiments
For pore-formation assays, the SUV membrane fractions
containing Cry1Ab oligomers were suspended in 100 μl of
10 mM Ches and 300 mM KCl (pH 9). These oligomers were
formed after interaction of trypsin-activated Cry1Ab toxin or
protoxin with the cadherin fragment in the presence of trypsin
as reported above in the ‘Incorporation of oligomers into SUVs
(small unilamellar vesicles)’ section. PLBs were made using
the method of Mu¨eller et al. [36] with DPPC (1,2-dipalmitoyl-
sn-glycero-3-phosphocholine) (Avanti Polar Lipids) (20 mg/ml
in n-decane). Typical bilayer capacitance values were between
250 and 350 pF. Buffer solution (10 mM Ches and 300 mM
KCl, pH 9) was added to the cis compartment, whereas, in the
trans compartment, the buffer solution was modified to contain
150 mM KCl. Different KCl concentrations in the cis and trans
compartments facilitate fusion of membrane vesicles to the bilayer
by adding the vesicle suspension containing Cry1Ab protein
samples to the cis compartment, whereas the trans was held
at virtual ground. All experiments were performed at room
temperature. Ionic currents were recorded with a Dagan 3900A
patch-clamp amplifier. Currents were filtered at 200 or 500 Hz
and digitized online at 1 or 2 kHz respectively, and analysed on a
personal computer using a Digidata 1200 interface and Axotape
and pClamp software (Axon Instruments). Histograms with the
most frequently observed currents were constructed with pSTAT
program version 6.0.5 using Simplex SLQ fitting. The open
probability (Po) was calculated by (to/ti)/N, where to represents
the sum of open times by N channels with different open levels
over the total recording time interval (ti).
Association and dissociation binding assays of Cry1Ab toxins to
BBMVs
For binding association assays, 2 nM activated Cry1Ab toxin was
incubated with 10 μg of BBMVs for 0, 20, 40, 60 and 100 min
at 30 ◦C in binding buffer (PBS and 0.1% BSA, pH 10.5) with
slow agitation. After 100 min of binding, the time-dependent
dissociation process was analysed after dilution of the mixture
with 20-fold volumes of the same buffer. The unbound toxin
was removed by centrifugation at ∼18500 g for 10 min and the
membrane pellets containing the bound toxin were washed once
with same buffer, suspended in 10 μl of PBS and 3 μl of 4×
Laemmli sample buffer and heated for 5 min at 50 or 100 ◦C.
These samples were separated by SDS/PAGE (8% gels) and
electrotransferred on to PVDF membranes. Proteins were revealed
in Western blot assays using rabbit anti-Cry1Ab antibodies as
described above.
Toxicity assays against M. sexta larvae
Bioassays were performed with M. sexta neonatal larvae.
Different doses of activated toxin or protoxin solutions were
poured on to the diet surface in 24-well polystyrene plates and
allowed to dry. A total of 24 neonatal M. sexta larvae per plate
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
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Figure 1 Binding of Cry1Ab toxin or protoxin to a cadherin fragment (CR7–CR12) from M. sexta larvae
ELISA saturation binding assays were performed by fixing 1 μg of cadherin fragment per well in ELISA plates and then incubating with different concentrations of pure activated Cry1Ab toxin (A) or
Cry1Ab protoxin (B). Bound Cry protein was revealed with polyclonal anti-Cry1Ab antibody. Data were analysed using Scatchard analysis with SigmaPlot.
per dose were analysed in triplicate, and five different doses were
assayed. Mortality was monitored after 7 days and the LC50 (50%
lethal concentration) was analysed using Probit (LeOra Software).
RESULTS
Analysis of the binding interaction of Cry1Ab protoxin or toxin with
cadherin receptor
Interaction with the cadherin receptor is a crucial step in the
mode of action of Cry toxins. It was shown previously that
Cry1Ac protoxin can bind Pectinophora gossypiella cadherin
[37]. However, the kinetics of this binding was not determined. In
the present study, we analysed, using ELISA saturation binding
assays, the binding of Cry1Ab protoxin or activated Cry1Ab toxin
with the M. sexta cadherin fragment, which contains the three
known toxin-binding sites (CR7, CR11 and CR12) [26]. We found
that Cry1Ab protoxin binds to the cadherin receptor fragment with
high affinity (Figure 1). The apparent dissociation constant (Kd)
of the Cry1Ab protoxin–CR7–CR12 interaction (6.8 +− 0.4 nM)
was similar to that of the Cry1Ab toxin–CR7–CR12 interaction
(3.3 +− 0.6 nM), suggesting that, in vivo, both the protoxin and the
activated monomeric toxin would be able to bind to the cadherin
receptor.
Oligomerization of Cry1Ab toxin or protoxin in solution, after
interaction with cadherin receptor
To determine the role of protoxin binding to cadherin, we
compared oligomerization of the Cry1Ab trypsin-activated toxin
(Figure 2A) with that of the protoxin (Figure 2B). This comparison
was done after interaction with the cadherin fragment from M.
sexta, in the presence or absence of trypsin or midgut juice
proteases. The thermosensitivity of the oligomeric structures
was analysed by Western blot assays, incubating the samples
at different temperatures (25, 50 or 100 ◦C) for 5 min before
SDS/PAGE. In control experiments, the Cry1Ab proteins were
also incubated for 5 min at these temperatures, showing that
these incubations did not affect their molecular mass as resolved
by SDS/PAGE (Figures 2A and 2B, lanes 1–3). We were
surprised that incubation of trypsin-activated toxin with cadherin,
in the absence of proteases, caused significant changes in
the Cry1Ab structure to induce its oligomerization, forming
high-molecular-mass structures (150–250 kDa) that were SDS-
resistant but temperature-sensitive, since 5 min of incubation at
100 ◦C completely disassembled the oligomeric structures into
60 kDa monomeric toxin (Figure 2A, lanes 4–6). Supplementary
Figure S1 (http://www.biochemj.org/bj/459/bj4590383add.htm)
shows that these structures were not formed by interaction with
other receptors such as APN or ALP. Figure 2(A) (lanes 7–
9) shows that similar oligomeric structures were observed if
the activated toxin was incubated with the cadherin fragment in the
presence of trypsin, suggesting that no further cleavages were
induced by trypsin treatment. However, if this incubation was
carried out in the presence of proteases from insect midgut, the
oligomeric structure that is formed is slightly different, showing
a single band of 250 kDa when the sample was heated at 25 ◦C
before SDS/PAGE. This oligomeric structure was highly sensitive
to temperature, since its mass is reduced to 130 kDa when heated
at 50 ◦C and disassembled into monomeric toxin when
heated at 100 ◦C before SDS/PAGE (Figure 2A, lanes 10–12).
A similar experiment, where the activated Cry1Ab toxin was
incubated with cadherin in the presence or absence of proteases,
but revealed with an anti-cadherin antibody (Supplementary Fig-
ure S2 at http://www.biochemj.org/bj/459/bj4590383add.htm),
showed that the cadherin was not part of the oligomeric
toxin structures (Supplementary Figure S2, lanes 4–6).
Furthermore, the cadherin was cleaved after incubation with
trypsin (Supplementary Figure S2, lanes 7–9) or midgut juice
(Supplementary Figure S2, lanes 10–12).
In contrast, incubation of Cry1Ab protoxin with the cadherin
fragment did not affect its apparent molecular mass of 130 kDa
(Figure 2B, lanes 4–6). However, in the presence of trypsin
(Figure 2B, lanes 7–9) or midgut juice from M. sexta (Figure 2B,
lanes 10–12), most of the protoxin is transformed into monomeric
toxin, and oligomers of molecular mass close to 250 kDa are
produced. These oligomers are stable after heat treatment at
50 ◦C (compare lanes 7 and 8 or lanes 10 and 11 of Figure 2B).
It is evident that these structures are also disassembled after
incubation at 100 ◦C. However, in the presence of midgut juice,
some oligomeric structure still could be observed after incubation
at this temperature (Figure 2B, lane 12).
These data indicate that interaction of cadherin facilitates
oligomerization of Cry1Ab and that two different oligomeric
structures are formed in solution depending on whether
c© 2014 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Licence (CC-BY) (http://creativecommons.org/licenses/by/3.0/) which
permits unrestricted use, distribution and reproduction in any medium, provided the original work is properly cited.
Two Bacillus thuringiensis Cry1A pre-pores are involved in toxicity 387
Figure 2 Oligomerization in solution of Cry1Ab toxin or protoxin, after
interaction with a cadherin fragment from M. sexta
Monomeric trypsin-activated Cry1Ab toxin (A) or protoxin (B) were incubated in solution at
37◦C for 1 h with the cadherin CR7–CR12 fragment in the presence or absence of trypsin or
midgut juice proteases from M. sexta. After incubation, samples in Laemmli sample buffer were
heated for 5 min at different temperatures and revealed in Western blot assays with anti-Cry1Ab
antibody. Lanes 1–3, control samples of Cry1Ab toxin or protoxin; lanes 4–6, incubation of
Cry1Ab toxin or protoxin with the cadherin fragment; lanes 7–9, incubation of Cry1Ab toxin
or protoxin with the cadherin fragment in the presence of trypsin; lanes 10–12, incubation of
Cry1Ab toxin or protoxin with the cadherin fragment in the presence of midgut juice from M.
sexta larvae. Molecular-mass markers were PageRuler pre-stained protein ladder (Fermentas)
and molecular masses are indicated in kDa. Numbers under the bands represent the percentage
of each band on the blot calculated after densitometric analysis of the bands using ImageJ
software and using one band of the same mass in the gel as 100 % reference.
the interacting molecule is a trypsin-activated toxin or
protoxin.
Insertion of Cry1Ab pre-pore structures into SUVs or in BBMVs from
M. sexta
To determine whether the observed oligomers are able to insert
into the membrane, similar oligomerization assays in solution
were performed with trypsin-activated Cry1Ab or Cry1Ab
protoxin. These protein mixtures were incubated afterwards
for 1 h with SUVs. The membrane pellets, containing proteins
inserted into the vesicles, were separated by ultracentrifugation,
resolved by SDS/PAGE and revealed by Western blot. Figure 3
shows how the different oligomeric structures partition into the
SUV membrane. First, when the activated Cry1Ab toxin was
incubated in solution with cadherin in the absence (Figure 3A,
lanes 1–3) or presence (Figure 3A, lanes 7–9) of trypsin, the
oligomer that is formed in solution did not insert efficiently into
the SUVs (Figure 3A, lanes 4–6 and 10–12 respectively). A
small amount of toxin could be detected in the membrane pellet,
which could represent some protein precipitation, since it was
not observed at the three temperatures (Figure 3A, lanes 4–6).
The oligomer obtained after the Cry1Ab toxin was incubated in
solution with cadherin in the presence of midgut juice (Figure 3A,
lanes 13–15) was partially able to insert into the liposome
(Figure 3A, lanes 16–18, arrow).
In contrast, the 250-kDa oligomeric structure obtained after
incubation of Cry1Ab protoxin with cadherin in the presence of
trypsin (Figure 3B, lanes 1–6) or midgut juice (Figure 3B, lanes
7–12) was able to insert into SUVs (Figure 3B lanes 1–3 and
7–9 respectively, arrow), and the supernatant only contained the
monomeric toxin (Figure 3B, lanes 4–6 and 10–12). A control
of the different toxin and protoxin incubations without liposomes
showed an absence of protein precipitation (results not shown).
It is important to note that oligomeric structures formed
in solution from activated toxin (Figure 3A, lanes 7–9 and
13–15) were able to insert efficiently into BBMVs isolated
from M. sexta as shown in Figure 4(A). The oligomers were
recovered in the BBMV pellet, indicating that the presence
of receptors is important for insertion of these oligomeric
structures into the membrane, supporting the sequential binding
model.
We also analysed the oligomerization of Cry1Ab toxin or
protoxin after their direct interaction with BBMVs isolated
from M. sexta, which contain all toxin receptors. Figure 4(B)
shows that when activated Cry1Ab toxin was incubated with
BBMVs, heat-sensitive 150–250-kDa oligomeric structures were
observed associated with the membrane pellet. If the Cry1Ab
protoxin was incubated with BBMVs (Figure 4C), two different
oligomeric structures (arrows) could be observed associated with
the membrane pellet, a 150–250-kDa heat-sensitive oligomer
(Figure 4C, lanes 10–13) and a 250-kDa oligomer that is more
resistant to heat treatment (Figure 4C, lanes 10–16). These results
show that both pre-pore oligomeric structures are able to insert
into BBMVs.
Pore-formation activity
To determine whether oligomers formed from activated toxin or
protoxin are able to induce pore formation, we analysed the pore-
formation activity of the membrane-associated proteins using
voltage clamp on PLBs as described in the Experimental section.
Figures 5(A)–5(C) show current–voltage (I–V) relationships of
the induced currents by the different samples. Figures 5(D)–
5(F) show 30-s records of the pores induced by these samples.
Liposomes with associated Cry proteins were fused to PLBs
before the pore-formation activity was analysed [25–27,33]. The
samples obtained from activated Cry1Ab toxin formed ionic
pores that were similar to the pores induced by monomeric
toxin reported previously [14,16–20], showing pore activity with
multiple subconducting states that are difficult to resolve and
with low open probability with values of 0.3–0.6 (Figures 5A,
5B, 5D and 5E). To analyse these currents, histograms
with the most common ionic currents at − 80 mV and at
80 mV were constructed and these data were plotted as an I–V
graph (Figures 5A and 5B). The oligomer that is formed after
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Figure 3 Partition into SUVs of oligomeric structures formed in solution from Cry1Ab toxin or protoxin
(A) Samples containing oligomeric and monomeric structures of Cry1Ab toxin obtained in solution after incubation with the cadherin fragment (lanes 1–3), with the cadherin fragment in the presence
of trypsin (lanes 7–9), or with the cadherin fragment and midgut juice proteases from M. sexta (lanes 13–15) at 37◦C (as in Figure 2). Samples were incubated for 1 h with SUV liposomes, and
finally centrifuged at 157 000 g for 30 min. Pellet samples were recovered (in a total volume of 60 μl of PBS) and divided into three different tubes (20 μl each), Laemmli sample buffer was added,
and each was heated for 5 min at a different temperature and revealed in Western blot assays with anti-Cry1Ab antibody. Proteins obtained in pellets represent proteins incorporated into the SUV
membrane obtained under the three different conditions (lanes 4–6, 10–12 and 16–18). (B) Samples obtained after incubation in solution of Cry1Ab protoxin with the cadherin fragment and trypsin
or midgut juice proteases from M. sexta at 37◦C as in Figure 2 were incubated afterwards for 1 h with SUV liposomes, and finally centrifuged at 157 000 g for 30 min. Pellets (recovered as above in
a total volume of 60 μl of PBS were divided into three different tubes) or 20 μl of supernatant samples were used. Laemmli sample buffer was added to each sample, which were each then heated
for 5 min at a different temperature before being revealed in Western blot assays with anti-Cry1Ab antibody. Lanes 1–3, proteins obtained in SUV pellets; lanes 4–6, proteins from supernatants after
incubation of Cry1Ab protoxin with the cadherin fragment in the presence of trypsin; lanes 7–9, proteins incorporated into membrane pellet; lanes 10–12, proteins in the supernatants from samples
obtained after incubation of Cry1Ab protoxin with the cadherin fragment in the presence of midgut juice. Arrows point to the Cry1Ab oligomers incorporated into membrane pellets of SUVs. Numbers
under the bands represent the percentage of each band on the blot calculated after densitometric analysis of the bands using ImageJ software and using one band of the same mass in the gel as
100 % reference. Molecular masses are indicated in kDa.
incubation of activated toxin with cadherin and midgut juice
induces macroscopic currents with multiple subconducting states,
probably due to insertion of multiple pores (results not shown). In
contrast, the oligomer obtained from Cry1Ab protoxin incubated
with cadherin and trypsin induces the formation of highly stable
ion pores with high open probability (Po close to 1) (Figures 5C
and 5F), similar to the previously reported pores induced by pure
oligomeric structures obtained from Cry1Ab protoxin activated
with midgut juice in the presence of svFv73 antibody which
mimics cadherin receptor [16,25–27]. The higher current in the
samples obtained with Cry1Ab protoxin could be due to insertion
of several pores in the same liposome that fuses to the lipid bilayer.
The samples obtained after interaction of Cry1Ab protoxin with
cadherin and midgut juice also induced macroscopic currents with
stable open probability probably due to the insertion of multiple
pores (results not shown).
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Figure 4 Partitioning into BBMVs isolated from M. sexta larvae of oligomers obtained previously in solution and oligomerization of Cry1Ab toxin or protoxin
after direct interaction with BBMVs
(A) BBMV incorporation of oligomers previously formed in solution after incubation of Cry1Ab toxin with the cadherin fragment in the presence of trypsin (lanes 1–3) or midgut juice from M. sexta
(lanes 4–6). Protein samples obtained in solution were incubated for 1 h with BBMVs, and finally centrifuged at 157 000 g for 30 min. (B and C) Oligomer formation after direct interaction with
BBMVs. Cry1Ab toxin (B) or Cry1Ab protoxin (C) were incubated at 37◦C for 1 h with BBMVs. After incubation, the samples were centrifuged at 157 000 g for 30 min. The pellet samples were
washed with buffer by centrifugation and finally suspended in Laemmli sample buffer and each was heated for 3 min at a different temperature before resolving by SDS/PAGE and Western blot assay
using anti-Cry1Ab antibody. Arrows point to the two types of oligomers that are formed: a 150–250-kDa heat-sensitive oligomer (lanes 10–13) and a 250-kDa oligomer that is more resistant to heat
treatment (lanes 10–16). Numbers under the bands represent the percentage of each band on the blot calculated after densitometric analysis of the bands using ImageJ software and using one band
of a similar mass in the gel as 100 % reference. Molecular masses are indicated in kDa.
Figure 5 Pore-formation activity in black lipid bilayers
Current–voltage (I–V ) relationship of the currents induced by activated Cry1Ab toxin (A and B) or Cry1Ab protoxin (C) after interaction with the cadherin fragment (A) or with cadherin fragment plus
trypsin (B and C) and recovered in SUV liposomes as described in the Experimental section. Representative ionic pore records of most common transitions induced by these samples are shown
in (D) and (E) for oligomers obtained from activated toxin (after incubation with cadherin or cadherin plus trypsin respectively) and (F) from Cry1Ab protoxin (after incubation with cadherin plus
trypsin). Records were obtained in asymmetrical 300 mM cis and 150 mM trans KCl conditions. Insets in (D)–(F) each show a small portion of the recorded pores marked with a small horizontal
line over the trace, on a millisecond timescale. Arrow in (F) indicates SUV liposome addition to the cis bilayer chamber., data after SUV addition;, data before SUV addition.
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Figure 6 Association and dissociation binding assays of Cry1Ab or F371A toxins to BBMVs isolated from M. sexta larvae
(A) Time-dependent association of monomeric Cry1Ab toxin to BBMVs was analysed for up to 100 min (lanes 1–5 and 9–13). After this time, the sample was diluted by addition of an excess of
20-fold volume of buffer and time-dependent dissociation was analysed for up to 60 min (lanes 6 and 7, and 14 and 15). Unbound toxin was removed by centrifugation and the membrane pellet
containing the bound toxin was analysed by Western blot assay with anti-Cry1Ab antibody. Samples in Laemmli sample buffer were heated at 50◦C (lanes 1–8) or at 100◦C (lanes 9–15) for 5 min
before SDS/PAGE and visualizing the proteins in Western blot assays. Lane 8 is control BBMVs without toxin incubation. Molecular masses are indicated in kDa. (B) Similar experiment to that
described in (A) performed with monomeric F371A mutant toxin. Densitometric analysis of the bands in the blot was carried out using ImageJ software to quantify binding. These values were plotted
as the percentage of binding against time. Closed symbols correspond to data of blots obtained after heating at 50◦C and open symbols correspond to data of blots obtained after heating at 100◦C.
Irreversible binding of Cry1Ab monomer to BBMVs is due to the
membrane insertion of the heat-sensitive oligomer
Association and dissociation binding assays of Cry1Ab toxin to
M. sexta BBMVs were performed to study the reversible and
irreversible binding components of the interaction of Cry1Ab
toxin with BBMVs. We analysed the time-dependent association
of Cry1Ab toxin with BBMVs up to 100 min. After this period,
the time-dependent dissociation process was determined up to
60 min, by diluting the mixture with 20-fold volumes of buffer.
The samples were centrifuged, and toxin bound to BBMVs was
visualized by Western blotting. Total binding corresponds to the
toxin bound after 100 min of association, and the irreversible
binding was determined as the bound toxin that remains after
60 min under dissociation conditions.
To detect the oligomeric structure of the Cry1Ab toxin, we
heated these samples for 5 min at 50 ◦C before resolving by
SDS/PAGE (Figure 6A, lanes 1–8). These samples were also
heated at 100 ◦C (Figure 6A, lanes 9–15). Figure 6(A) shows
that when Cry1Ab toxin is bound to BBMVs, an oligomeric
structure of 150–250 kDa was formed and it was incorporated
into the membranes as an SDS-resistant heat-sensitive oligomer
(Figure 6A, lanes 1–5) that disassembled if samples were heated
at 100 ◦C (Figure 6A, lanes 9–13). The dissociation assays
indicate that these oligomeric structures were not washed out
after dilution of the sample with a 20-fold higher amount of
buffer, suggesting a stable insertion of oligomeric molecules
into the membrane (Figure 6A, lanes 6 and 7, and 14 and
15). The irreversible Cry1Ab binding represented 57% of the
total toxin binding, as determined by densitometric analysis of
the bands (at 50 ◦C) using ImageJ software (NIH). A similar
experiment was performed with biotinylated Cry1Ab toxin,
and bound toxin was visualized with streptavidin coupled to
peroxidase. In this case, competition was carried out with a 500-
fold higher concentration of unlabelled toxin. Supplementary
Figure S3 (http://www.biochemj.org/bj/459/bj4590383add.htm)
shows that Cry1Ab bound BBMVs in an irreversible way and,
after competition with unlabelled toxin, 59% of the toxin
remained bound to the BBMVs (Supplementary Figure S3). If the
sample was heated at 100 ◦C before loading the gels, a monomeric
band was observed (Supplementary Figure S3, lanes 9–14),
such as shown previously in multiple binding assays performed
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Figure 7 Analysis of binding of Cry1AbMod to the cadherin fragment (CR7–CR12) and oligomerization of Cry1AbMod toxin and protoxin
ELISA saturation binding assays were performed by fixing 1 μg of cadherin fragment in ELISA plates and incubating with different concentrations of pure Cry1AbMod protoxin (A) or pure
trypsin-activated Cry1AbMod toxin (B). Bound protein was revealed with polyclonal anti-Cry1Ab antibody. Data were analysed using Scatchard analysis with SigmaPlot. (C) Oligomerization in
solution of Cry1AbMod or Cry1Ab toxins after interaction with the cadherin fragment, in the presence of midgut juice proteases from M. sexta at 37◦C. After incubation, each sample in Laemmli
sample buffer was heated for 5 min at a different temperature and revealed by Western blot assay with anti-Cry1Ab antibody. Lanes 1–4, control Cry1AbMod toxin or Cry1Ab toxin; lanes 5–8,
incubation of Cry1AbMod toxin or Cry1Ab toxin with the cadherin fragment in the presence of midgut juice. (D) Oligomerization of Cry1AbMod or Cry1Ab, in their protoxin or activated toxin
forms after interaction with BBMVs isolated from M. sexta larvae. Lanes 1–3, incubation of Cry1Ab protoxin; lanes 4–6, Cry1AbMod protoxin with BBMVs; lanes 7–9, Cry1Ab toxin; lanes 10–12,
Cry1AbMod toxin after incubation for 1 h with BBMVs at 37◦C. After incubation, samples were centrifuged at 157 000 g for 30 min. The pellet samples were washed with buffer by centrifugation
and finally suspended in Laemmli sample buffer, heated at different temperatures for 3 min and revealed in Western blot assays with anti-Cry1Ab antibody. Numbers under the bands represent the
percentage of each band on the blot calculated after densitometric analysis of the bands using ImageJ software and using one band of the same mass in the gel as 100 % reference. Molecular masses
are indicated in kDa.
with biotinylated toxins [11,25,26,35]. However, if samples were
heated at 50 ◦C, no band was observed (Supplementary Figure S3,
lanes 1–6), indicating that the biotin molecule is not accessible
to the streptavidin, probably because it is buried within the
oligomeric toxin structure, which was clearly observed if the blots
were revealed with anti-Cry1Ab antibody (Figure 6A, lanes 1–7).
The Cry1Ab F371A mutant that is affected in its irreversible
binding to BBMVs [28,38] was used as a control in these
experiments. Heat-sensitive oligomers were observed when
trypsin-activated F371A mutant was incubated with BBMVs
(Figure 6B, lanes 1–5 and lanes 9–13). Nevertheless, binding of
these oligomeric structures is highly reversible since all binding
was lost during the dissociation assay (Figure 6B, lanes 6 and 7,
and 14 and 15).
Overall, these data indicate that irreversible binding of trypsin-
activated Cry1Ab toxin with BBMVs of M. sexta correlates with
a stable insertion of the oligomeric structure of the toxin into
the membrane. Also, the monomeric toxin was not inserted
into the membrane, since oligomeric structures were observed at
the shortest time of incubation (t0). Mutant F371A is not affected
in oligomerization, since oligomer formation can be observed in
the membrane pellet, but insertion of these oligomers into the
membrane is slower and completely reversible. It did not display
a stable interaction with BBMVs.
Characterization of Cry1AbMod toxin
Cry1AbMod is a mutant protein where the N-terminal end,
including helix α-1 and a small part of helix α-2a, is deleted
[29]. We activated the Cry1AbMod protoxin with trypsin and
purified the trypsin-activated Cry1AbMod toxin by ion-exchange
chromatography. Analyses of Cry1AbMod toxin and protoxin
binding to the cadherin fragment CR7–CR12 show that the
Cry1AbMod protoxin was able to bind the cadherin fragment
with a similar affinity as that of the Cry1Ab protoxin (Figure 7A),
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Table 1 Toxicity of Cry1Ab and Cry1AbMod against M. sexta larvae
LC50, 50 % lethal concentration, analysed statistically with Probit software.
Protein LC50 (ng/cm2) (90 % confidence limits)
Cry1Ab protoxin 1 (0.5–1.7)
Cry1Ab toxin 2 (1.6–2.7)
Cry1AbMod protoxin 2 (1.3–3.0)
Cry1AbMod toxin 15 (11.2–18.3)
whereas the activated Cry1AbMod toxin lost its ability to bind
cadherin (Figure 7B).
It was reported that the Cry1AbMod protoxin forms a 250-
kDa oligomeric structure after trypsin activation in the absence
of cadherin. This structure is resistant to temperature and inserts
into synthetic liposomes [27,29]. Furthermore, the Cry1AbMod
protoxin oligomerizes more efficiently at high alkaline pH and
in the presence of SUV liposomes than in solution [27]. Thus
we analysed the oligomerization of the ion-exchange-purified
trypsin-activated Cry1AbMod toxin, showing that it was unable to
oligomerize in solution after midgut juice treatment (Figure 7C).
Oligomerization of Cry1AbMod was also analysed in the presence
of BBMVs and we found that the Cry1AbMod protoxin formed
oligomers that insert into BBMVs. In contrast, the activated
Cry1AbMod toxin oligomerized and inserted into BBMVs less
efficiently (Figure 7D).
The insecticidal activity of the protoxin and the activated
Cry1AbMod toxin against M. sexta larvae were analysed. Table 1
shows that Cry1AbMod toxin had 8-fold lower insecticidal
activity than the Cry1AbMod protoxin. In contrast, both
wild-type Cry1Ab toxin or protoxin have similar insecticidal
activities against M. sexta (Table 1). These data could explain
why Cry1AbMod lost its potency against certain susceptible
larvae [29,39,40], since the activated toxin results in a
protein with reduced oligomerization and is unable to bind
cadherin. These data suggest that participation of the activated
toxin is important for insecticidal activity against susceptible
larvae.
DISCUSSION
Oligomerization of Cry toxins takes place outside the membrane
and the induced oligomer in solution is similar to the oligomer that
is formed in the presence of BBMVs
Our data indicate that two distinct Cry1Ab pre-pore structures
are formed in solution after cadherin binding, depending on the
Cry protein involved, whether it is the trypsin-activated toxin
or the protoxin. Both the activated toxin and protoxin bind the
cadherin fragment CR7–CR12 with high affinity from M. sexta
larvae (Figure 1). The interaction of Cry1Ab toxin with the
cadherin fragment is sufficient to induce the formation of 150–
250-kDa oligomeric structures in solution, and no extra cleavage
is needed for the formation of these oligomers (Figure 2A).
Trypsin treatment did not affect the mass of these oligomers
(Figure 2A). However, these oligomers do not insert into synthetic
liposomes efficiently (Figure 3A) and form pores with multiple
subconducting states and low open probability (Figures 5A,
5B, 5D and 5E). Midgut juice treatment after interaction of
Cry1Ab toxin with cadherin induces a change in the mass of the
oligomers (Figure 2A), and these structures show slightly better
insertion into synthetic membranes (Figure 3A). Importantly,
oligomers that were formed after interaction of Cry1Ab toxin
with cadherin readily insert into BBMVs (Figure 4A). Thus pre-
pore structures formed outside the bilayer require other proteins
to insert efficiently into the membrane, such as has been proposed
previously for APN or ALP receptors [8,9], supporting the
sequential binding model of toxin pore formation [12].
In contrast, incubation of protoxin with the cadherin fragment
and midgut juice proteases or trypsin in solution induces the
formation of a 250-kDa oligomer that inserts into synthetic
liposomes, as demonstrated previously [16,25–27]. Analyses of
pore-formation activity in black lipid bilayers of these oligomeric
structures showed the induction of stable ion pores with high open
probability (Figures 5C and 5F) as reported previously [16,25–
27].
An important conclusion of the present study is that interaction
with cadherin receptor is required to induce oligomerization of
Cry1Ab toxin or protoxin. Incubation with other receptors such as
those for APN and ALP did not induce Cry1Ab oligomerization
(Supplementary Figure S1), but these other receptors may be
important for insertion of Cry1Ab oligomers into BBMVs
(Figure 4A). Both oligomeric structures were SDS-resistant and
heat-sensitive. However, the 250-kDa oligomer obtained from
Cry1Ab protoxin was shown to be more heat-resistant, since part
of it could be observed even after heating the samples at 100 ◦C
(Figures 2B and 4C). Importantly, the formation of this structure
in vitro seems to be less efficient, since it was less abundant than
the oligomeric structure observed after interaction of Cry1Ab
toxin with cadherin (Figure 2). This may be due to degradation
of the cadherin fragment by midgut juice proteases as shown in
Supplementary Figure S2.
Oligomerization of Cry1Ab toxin or protoxin in the presence of
BBMVs was also analysed. Cry1Ab toxin induces the formation
of oligomeric structures of 150–250 kDa that are highly sensitive
to heat, similar to those that are produced in solution (Figure 4B).
In contrast, the Cry1Ab protoxin induces the formation of two
oligomeric structures (Figure 4C): one that is highly sensitive to
heat and the other of 250 kDa that is more resistant to heat. The
latter is similar to those that are produced in solution after protoxin
interaction with cadherin and midgut juice protease treatment
(Figure 2). In the literature, there are multiple examples that show
that pore-formation activity of Cry toxins is highly improved in
the presence of BBMVs from target insects such as M. sexta
[16,41], Lymantria dispar [20], Spodoptera frugiperda [42] and
Heliothis virescens [43] or in the presence of aminopeptidases
and ALPs from M. sexta [44]. These data suggest that the presence
of receptors in the BBMVs is essential for Cry toxin action by
improving their pore-formation activity. We propose that cadherin
induces pre-pore formation and that APN and ALP facilitate
its insertion into the membrane. In the present study, we have
shown that interaction of Cry1Ab toxin or protoxin with BBMVs
results in the formation of oligomeric structures that insert into
the membrane. The monomeric toxin is not observed in the BBMV
membrane pellet, suggesting that monomeric Cry1Ab toxin does
not insert into the target membrane (Figures 4 and 6).
It was shown previously that Cry1Aa toxin, which is highly
related to Cry1Ab, also formed oligomeric structures in solution
when it is incubated in the presence of a fragment from Bombyx
mori cadherin BtR-175 containing the Cry1Aa-binding sites,
forming a heat-sensitive oligomer similar to that obtained in
the presence of B. mori BBMVs [45]. In addition, other studies
have shown oligomerization of different trypsin-activated Cry1A
toxins after incubation with BBMVs isolated from different
susceptible insects [46–49]. These structures are inserted into
the membrane, have molecular masses higher than 200 kDa and
were heat-sensitive, being dissociated into monomeric structures
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if they were heated at temperatures higher than 70 ◦C [46–48]. It
is important to mention that all reports of oligomerization of Cry
toxins involve interactions with cadherin or with BBMVs from
susceptible insects that contain receptor molecules [12,13,46–
50]. These reports are in agreement with the results of the present
study which show that interaction with cadherin is a key step
that induces oligomerization of Cry1Ab toxin. Further evidence
that supports the importance of the cadherin receptor for toxin
oligomerization is that a fragment of the M. sexta cadherin
containing the Cry1Ab-binding sites increases the insecticidal
activity of Cry1Ab when fed together with the toxin to different
larvae [51,52]. This enhancement in toxicity of Cry toxin by this
cadherin fragment was shown to correlate with Cry1Ab oligomer
formation [53]. In addition, cadherin fragments isolated from
different insect orders such as dipterans or coleopterans also
enhanced toxicity of specific Cry toxins active against these insect
orders [54,55].
The only exceptions of Cry toxin oligomerization without
receptors are mutant toxins that are cleaved between helices α-2a
and α-2b or have helices α-1 and α-2a deleted [27,29,45,56–
59]. One example is Cry1Aa mutant S373C, which forms heat-
sensitive oligomers in solution in the absence of receptors or
BBMVs. This mutant is cleaved in the loop between helices α-2a
and α-2b after activation, resulting in the loss of helices α-1 and
α-2a [45]. Another example is the Cry1AMod protoxins, where
helix α-1 and part of helix α-2 are deleted by genetic engineering
and these are able to form 250-kDa oligomers in the absence
of cadherin interaction [27,29]. The third example is Cry4Ba
protein, which is a special case, since it is a native protoxin that
is capable of forming toxin oligomers when it is proteolytically
activated in the presence of liposomes and in the absence of a
cadherin receptor [56–58]. Pore-formation assays in PLBs showed
that Cry4Ba oligomers were proficient in forming ion pores [56].
The crystal structure of Cry4Ba showed that, during activation of
Cry4Ba protoxin with chymotrypsin, helices α-1 and α-2a were
removed and the cleaved protein was crystallized in a trimeric
array [58]. Similar results were reported after crystallization of
Cry5Ba, showing a cleavage in the corresponding amino acid
after helix α-2a and a similar organization of a trimeric array in
its crystal structure [59]. It is relevant to mention that silencing
experiments of cadherin expression in Aedes aegypti by RNAi
showed that Cry4Ba does not rely on cadherin molecules for
toxicity [56]. All of these data show that cleavage of Cry protoxins
in the region between helices α-1 and α-2a is important to
induce their oligomerization in the absence of toxin receptors.
However, the present study has shown that, in vitro, the interaction
of activated Cry1Ab toxin with cadherin is enough to form a
pre-pore oligomeric structure. But these oligomers require other
receptors to insert efficiently into the membrane, since insertion
into BBMVs is highly efficient when compared with insertion into
synthetic liposomes where insertion is inefficient (compare
Figures 3A and 4A).
Monomeric Cry toxins did not insert into BBMVs and irreversible
binding of Cry toxins to BBMVs correlated with stable insertion of
oligomer structures into the membrane
It has been argued that irreversible binding of different Cry toxins
to BBMVs indicate that a monomeric structure of these toxins was
able to insert into the membrane [14,28]. We analysed the kinetics
of association and dissociation of Cry1Ab toxin with M. sexta
BBMVs. Dissociation assays have been used to determine the
amount of toxin that remains irreversibly associated with BBMVs
[28,60]. Using such assays, we found that binding of Cry1Ab toxin
with BBMVs correlates with the formation of a heat-sensitive
oligomer, and that irreversible binding to BBMVs correlated with
the presence of this structure associated with the membrane pellet.
These data are supported by the analysis of irreversible binding
of Cry1Aa toxin to B. mori BBMVs, where it was shown that
irreversible binding is due to the insertion of a heat-sensitive
oligomeric structure into the membrane [47].
As a control in our experiments, we analysed the binding of the
non-toxic Cry1Ab F371A mutant that is affected in its irreversible
binding to BBMVs [28]. It was reported that the loss of irreversible
binding of this mutant is due to a lack of toxin insertion into the
membrane [28,61]. It was also shown that the monomeric structure
of this mutant was able to bind APN and ALP with a similar
affinity as did the wild-type toxin. In contrast, the oligomeric form
of this mutant was severely affected in binding to these receptors
[9]. In the present study, we have shown that F371A toxin binding
to BBMVs is correlated with the formation of a heat-sensitive
oligomer. This binding was completely dissociated after dilution
with buffer, demonstrating further that the irreversible component
of Cry toxin binding to BBMVs is due to the stable insertion of the
oligomer into the membrane. These data suggest that interaction of
the oligomeric structure with APN and ALP receptors is important
for insertion of the pre-pore into the membrane, as proposed
previously [9,62]. Such evidence supports the sequential binding
model of toxin pore formation. In this model, a pre-pore oligomer
structure is formed after Cry1Ab interaction with cadherin, and
binding of this oligomer to APN and ALP is necessary for its
membrane insertion in midgut epithelium cells.
Both oligomeric structures are functional
In the present study, we provide evidence that the different pre-
pore oligomer structures formed after Cry1Ab toxin or protoxin
interaction with cadherin have pore-formation activity in black
lipid bilayers (Figure 5).
We also show that, in contrast with Cry1Ab and
Cry1AbMod protoxins, the activated Cry1AbMod toxin is
affected in oligomerization (Figures 7C and 7D). This effect in
oligomerization correlated with a 8-fold reduction in insecticidal
activity of Cry1AbMod toxin to M. sexta larvae, providing
evidence that both oligomeric structures are functional and play
a role in the intoxication process (Table 1).
On the basis of the proposed role of cadherin in oligomerization
of the Cry toxin, it was predicted that Cry1AMod protoxins
would counter resistance linked to mutations affecting cadherin
expression [29]. Surprisingly, Cry1AMod protoxins have been
shown to counter resistance in seven different lepidopteran insects
with different mechanisms of resistance, including mutations
linked to ABCC2 (ATP-binding cassette C2) transporter,
aminopeptidase P genes or to low APN expression [29,39,40].
In the case of the ABCC2 transporter, it has been suggested
that it may have a role in facilitating oligomer insertion into
the membrane [63]. In the present study, we have shown
that insertion of the pre-pore oligomer formed from Cry1Ab
protoxin inserts readily into synthetic membranes (Figure 3B),
suggesting that this pre-pore has no further need of additional
receptor molecules to insert into the membrane. Such data
could explain why the Cry1AMod protoxins can counter
different resistance mechanisms including mutations in other
receptors that might be involved in toxin oligomer membrane
insertion.
It has also been shown that, in some lepidopteran species
analysed, Cry1AMod protoxins lost potency against susceptible
insects [29,39,40], although, in some other insects, the loss in
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potency of Cry1AbMod is not significant [27,39]. Surprisingly,
activated Cry1AbMod toxin lost its affinity for cadherin, whereas
the Cry1AbMod protoxin retained its high affinity for the CR7–
CR12 fragment (Figures 7A and 7B). It was suggested previously
that Cry1Ac activation could occur either before or after binding
of protoxin to cadherin and that binding of activated toxin or
protoxin could affect its toxicity [37]. Another study suggested
that interaction of activated Cry1Ab toxin with cadherin triggered
a cascade of intracellular events resulting in necrotic cell death
[64]. Therefore we cannot exclude the possibility that the loss
of potency of Cry1AMod protoxins against susceptible insects
could be related to the loss of a signal transduction component
since monomeric Cry1AbMod toxin is affected on cadherin
binding. In this regard, a recent observation showed that resistance
of a Helicoverpa armigera population to Cry1Ac-expressing
transgenic cotton in China is linked to a cadherin allele with
mutations in the cytoplasmic domain of cadherin [65]. These data
suggest that signal transduction mechanisms could be involved in
Cry1Ac toxicity at least in this insect species [65]. Nevertheless,
the fact that activated Cry1AbMod toxin was less efficient at
oligomerization than Cry1AbMod protoxin, may also indicate
that the loss of its potency could be due to lack or to the lower
amount of this oligomeric structure in the mechanism of action of
Cry1AbMod toxin.
Activation of the protoxin to toxin depends on proteases
present in each insect species, and this could explain the various
levels of Cry1AbMod potency loss in different susceptible
insects that have been tested. Potentially, these insects could
have different gut proteases that could affect the rate of toxin
formation from Cry1AMod protoxin [29,39,40]. Cry1AbMod
protoxin shows similar toxicity to native Cry1Ab against some
insect pests such as M. sexta, Ostrinia nubilalis, P. gossypiella
and Trichoplusia ni [27,39]. Nevertheless, Cry1AbMod protoxin
was up to 20-fold less toxic against other insects such as Plutella
xylostella [39]. Notably, in all cases analysed, Cry1AcMod
protoxin showed a higher loss of potency compared with
Cry1AbMod, such as up to 83-fold less toxicity against P.
gossypiella [29,39,40]. Such evidence suggests that different
processing rates of Cry1AMod protoxins to toxins by midgut
proteases in different insect species could correlate with the
differential loss of potency of Cry1AMod protoxins against
these susceptible lines. Importantly, Helicoverpa zea and H.
armigera populations that are highly resistant to activated
Cry1A toxins showed reduced resistance levels to Cry1A
protoxins [39,66–68]. Therefore, in these resistant populations,
a differential role for the two pre-pores mentioned in the
present study may determine the differential susceptibility to Cry
proteins.
Most of the PFTs are produced as protoxins, but the role of
protoxin fragments in PFT activity has not been analysed. Our
data indicate that the protoxin region of PFT molecules may have
a functional role that was selected for during evolution, because
the presence of this fragment in the protein allows triggering of
an alternative mechanism of action that, in some cases, could be
quite important [29,39,66–68]. The role of the protoxin region in
PFT action was analysed in aerolysin, where it was shown that
the C-terminal region that is cleaved after binding to its receptor
plays a crucial role for the activity of this PFT by preventing
aggregation during biosynthesis and controlling assembly of the
quaternary structure of the pre-pore on the membrane surface,
functioning as a chaperone [69]. Overall, our data show that Cry
toxins are versatile proteins that could exert toxicity by different
mechanisms of action and the protoxin molecules trigger the
formation of pre-pore structures involved in toxicity. The role
of protoxin molecules of other important PFTs in pore formation
and virulence remains to be analysed and would be a fruitful area
of investigation for the coming years.
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Figure S1 Incubation of Cry1Ab toxin with M. sexta APN or ALP proteins in
solution
Monomeric Cry1Ab toxin was incubated for 1 h with APN or ALP from M. sexta at 37◦C. After
incubation, samples were heated for 5 min at different temperatures and revealed in Western
blot assays with anti-Cry1Ab antibody. Molecular-mass markers were PageRuler pre-stained
protein ladder (Fermentas) and molecular masses are indicated in kDa.
Figure S2 Detection of cadherin after incubation for 1 h with trypsin-
activatedmonomeric Cry1Ab toxinwith the cadherin fragment in the presence
or absence of trypsin or midgut juice proteases from M. sexta at 37◦C
After incubation, samples were heated for 5 min at different temperatures and revealed in Western
blot assays with anti-cadherin antibody. Lanes 1–3, control Cry1Ab toxin; lanes 4–6, incubation
of Cry1Ab toxin with cadherin fragment; lanes 7–9, incubation of Cry1Ab toxin with cadherin
fragment in the presence of trypsin; lanes 10–12, incubation of Cry1Ab toxin with cadherin
fragment in the presence of midgut juice. Molecular masses are indicated in kDa.
1 Correspondence may be addressed to either of these authors (email mario@ibt.unam.mx or bravo@ibt.unam.mx).
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Figure S3 Association and dissociation binding assays of biotin-labelled Cry1Ab toxin bound to BBMVs from M. sexta larvae
Cry1Ab toxin was labelled with biotin, using biotinyl-N-hydroxysuccinimide ester, according to the manufacturer’s instructions (GE Healthcare). A 10μg amount of BBMV protein was incubated
in binding buffer with 5 nM biotinylated Cry1Ab toxin during time-dependent association up to 100 min (lanes 1–5 and 9–13). After this time, an excess of 500-fold unlabelled toxin was added
and time-dependent dissociation was analysed for up to 60 min (lanes 6 and 14). Unbound toxin was removed by centrifugation at ∼ 18 400 g for 10 min and the membrane pellet containing the
bound toxin was washed once with same buffer. The final pellet was suspended in Laemmli sample buffer and heated for 3 min at 50◦C (lanes 1–8) or 100◦C (lanes 9–15) before resolving by
SDS/PAGE. Lanes 7 and 15 are control BBMVs without toxin incubation. Lane 8 is control biotinylated Cry1Ab toxin. Proteins were electrotransferred on to PDVF membranes, and labelled protein
was detected with streptavidin coupled to horseradish peroxidase (HRP). Densitometric analysis of the bands in the blot was carried out using ImageJ software to quantify binding. These values were
plotted as the percentage of binding against time. Only data from blots obtained after heating at 100◦C were used in the plot, since biotinylated toxin could not be detected in the samples that
were heated at 50◦C which form oligomeric structures, suggesting that biotin is inaccessible to be recognized by the streptavidin protein. C, control BBMVs without toxin incubation. Molecular
masses are indicated in kDa.
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